As PARVB introduction was reported to suppress cellular growth of breast cancer cells with decreased Akt phosphorylation [49], [50], Parvb introduction in MEF also decreased phosphorylation of Akt in exposure to a growth factor or serum (Figure 7E). Here, PARVB is linked to breast carcinoma.